We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo
WHX Labs Dubai 2026
Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Circulating Stem Cells Point to Cardiovascular Risk

By Biotechdaily staff writers
Posted on 25 Feb 2003
A recent study found that the level of circulating endothelial progenitor cells, stem cells made in the bone marrow, might be used as an indicator of cardiovascular disease risk. The study appeared in the February 13, 2003, issue of The New England Journal of Medicine.

Researchers from the National Heart, Lung, and Blood Institute (NHLBI, Bethesda, MD, USA) measured the number of colony-forming units of endothelial progenitor cells in peripheral-blood samples from 45 men who were close to 50 years of age. The subjects had various degrees of cardiovascular risk but no history of cardiovascular disease. Endothelium-dependent and endothelium-independent function was assessed by high-resolution ultrasonography of the brachial artery.

They found a strong correlation between the number of circulating endothelial progenitor cells and the subjects' combined Framingham cardiovascular risk factor score. Cardiovascular disease risk was higher in those subjects with fewer endothelial progenitor cells. Measurement of flow-mediated brachial-artery reactivity also revealed a significant relation between endothelial function and the number of progenitor cells. In addition, endothelial progenitor cells from subjects at high risk for cardiovascular events had higher rates of in vitro senescence than cells from subjects at low risk.

"We believe that these endothelial progenitor cells patch damaged sites in blood vessel walls, explained senior author Dr. Toren Finkel, chief of the cardiology branch at the National Heart, Lung, and Blood Institute "When the cells start to run out, cardiovascular disease worsens. We do not yet know what causes their depletion but it may be related to the fact that the risk of cardiovascular disease increases as people age. For instance, the cells may be used up repairing damage done by other risk factors or those risk factors could directly affect the survival of the endothelial cells themselves.”




Related Links:
tional Heart, Lung, and Blood Institute (NHLBI)

Gold Member
Hybrid Pipette
SWITCH
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Silver Member
PCR Plates
Diamond Shell PCR Plates
Autoimmune Liver Diseases Assay
Microblot-Array Liver Profile Kit

Latest BioResearch News

Genome Analysis Predicts Likelihood of Neurodisability in Oxygen-Deprived Newborns
25 Feb 2003  |   BioResearch

Gene Panel Predicts Disease Progession for Patients with B-cell Lymphoma
25 Feb 2003  |   BioResearch

New Method Simplifies Preparation of Tumor Genomic DNA Libraries
25 Feb 2003  |   BioResearch